Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003933
Accepted
2024-12-30 00:15:06
Documents
1
Effectiveness Date
2024-12-27

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 598
  Complete submission text file 9999999995-24-003933.txt   1906
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283741 | Film No.: 241586819
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)